纳斯达克交易所已正式授予Scienture Holdings, Inc.额外180天的宽限期,该公司须在此期间内将其股价提升至1美元以上,以满足交易所的最低报价规定。
此次延期为这家生物科技企业提供了关键缓冲期,使其能够通过战略调整或业务优化等方式重新达到上市标准。若未能按时合规,公司将面临退市风险。
纳斯达克交易所已正式授予Scienture Holdings, Inc.额外180天的宽限期,该公司须在此期间内将其股价提升至1美元以上,以满足交易所的最低报价规定。
此次延期为这家生物科技企业提供了关键缓冲期,使其能够通过战略调整或业务优化等方式重新达到上市标准。若未能按时合规,公司将面临退市风险。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.